Antianginal effects of chromonar. A combined investigation.
D000328:Adult; D000367:Age Factors; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003374:Coumarins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004048:Diethylamines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006016:Glycolates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000627:therapeutic use; D005082:Physical Exertion; D010919:Placebos; D044469:Racial Groups; D012737:Sex Factors; D013223:Statistics as Topic; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D003374:Coumarins; D004048:Diethylamines; D006016:Glycolates; D010919:Placebos; D014665:Vasodilator Agents; D005996:Nitroglycerin